|Amlodipine||Calcium channel blocker|
The drug combination atorvastatin/amlodipine (trade names Caduet in the US, Australia and Russia, and Envacar elsewhere) is a medication approved by the Food and Drug Administration (FDA) for the treatment of high cholesterol and high blood pressure. It is a fixed-dose combination drug containing a HMG-CoA reductase inhibitor and a calcium channel blocker being marketed by the pharmaceutical company Pfizer.
- "CADUET (amlodipine besylate/atorvastatin calcium) Tablets" (PDF). NDA 21-540/S-009. United States Food and Drug Administration. February 2010. Retrieved 2010-09-25.
- Devabhaktuni, Madhuri; Bangalore, Sripal (2009). "Fixed combination of amlodipine and atorvastatin in cardiovascular risk management: patient perspectives". Vascular Health and Risk Management. 5 (1): 377–387. doi:10.2147/vhrm.s3339. ISSN 1178-2048. PMC 2686256. PMID 19475775.
- Manufacturer's site (caduet.com)
|This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it.|